On Monday shares of Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) closed at $12.37. Company’s EPS growth for next 5 years is recorded as 40.00%. Dipexium Pharmaceuticals Inc. (DPRX) on May 14, reported a loss of $4.2 million in its first quarter. TheRead More
On Monday shares of Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) closed at $2.42. On May 13, Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM), announced the appointment of Jeng-Dar Yang, Ph.D. to the position of Vice President of Pharmaceutical Development effective May 4, 2015. Dr. YangRead More
On Monday shares of Roundy’s, Inc. (NYSE:RNDY) closed at $4.49. Company’s sales growth for last 5 years was 0.60% and EPS growth for next 5 years is recorded as 10.00%. On May 18, Roundy’s, Inc. (NYSE:RNDY) announced that it hasRead More
On Monday shares of Regions Financial Corporation (NYSE:RF) closed at $10.21. Company’s sales growth for last 5 years was -7.40% and EPS growth for next 5 years is recorded as 6.03%. On May 13, Regions Financial Corporation (NYSE:RF) is scheduledRead More
On Monday shares of ImmuCell Corp. (NASDAQ:ICCC) closed at $8.03. Company’s sales growth for last 5 years was 11.10%. On May 12, ImmuCell Corporation (NASDAQ:ICCC), announced financial results for its first quarter ended March 31, 2015. Total sales increased 49%Read More
On Monday shares of Verastem, Inc. (NASDAQ:VSTM) closed at $8.74. Company’s EPS growth for next 5 years is recorded as 1.74%. On May 11, Verastem, Inc. (NASDAQ:VSTM), reported financial results for the first quarter ended March 31, 2015, and alsoRead More
On Monday shares of Micron Technology, Inc. (NASDAQ:MU) closed at $26.76. Company’s sales growth for last 5 years was 27.80% and EPS growth for next 5 years is recorded as 15.00%. Micron Technology (NASDAQ:MU)‘s stock had its “buy” rating reissuedRead More
On Monday shares of Lakeland Industries Inc. (NASDAQ:LAKE) closed at $10.47. Company’s sales growth for last 5 years was -2.10% and EPS growth for next 5 years is recorded as 10.00%. On May 18, Lakeland Industries, Inc. (NASDAQ: LAKE), announcedRead More
On Monday shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE) closed at $14.20. Sorrento Therapeutics (NASDAQ:SRNE)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainright in a research report issued on Friday. They currently have a $20.00 target priceRead More
On Monday shares of CymaBay Therapeutics Inc. (NASDAQ:CBAY) closed at $3.34. May 15, CymaBay Therapeutics Inc. (NASDAQ:CBAY) announced that Harold Van Wart, Ph.D., President and Chief Executive Officer, will present a corporate update at the 2015 UBS Global Healthcare ConferenceRead More
Renewable Energy Systems Power Long-Term Growth Potential for Global Battery Demand 
Michael Baker International Names Gil Bosque, P.E., Vice President and Hamilton, New Jersey, Office Executive 
CleanSpark Announces Two New EV Contracts for GridFabric Software Subscriptions 
Biden’s Vacillating on Fracking Could Put America at Risk, said Energy Industry Leader Fred Schneiderman at 20 Days to Save the USA